Benjamin J. Drapkin

2.2k total citations
30 papers, 659 citations indexed

About

Benjamin J. Drapkin is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Benjamin J. Drapkin has authored 30 papers receiving a total of 659 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 15 papers in Molecular Biology and 8 papers in Epidemiology. Recurrent topics in Benjamin J. Drapkin's work include Lung Cancer Research Studies (18 papers), Neuroendocrine Tumor Research Advances (8 papers) and Cancer therapeutics and mechanisms (6 papers). Benjamin J. Drapkin is often cited by papers focused on Lung Cancer Research Studies (18 papers), Neuroendocrine Tumor Research Advances (8 papers) and Cancer therapeutics and mechanisms (6 papers). Benjamin J. Drapkin collaborates with scholars based in United States, Spain and Japan. Benjamin J. Drapkin's co-authors include Frederick R. Cross, Vincent Archambault, Amy E. Ikui, Anna F. Farago, Michael P. Rout, Brian T. Chait, Emmanuel J. Chang, Charles M. Rudin, Hossein Sadrzadeh and Donna Neuberg and has published in prestigious journals such as Cell, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Benjamin J. Drapkin

29 papers receiving 650 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benjamin J. Drapkin United States 13 416 233 113 102 83 30 659
Olaf Klingbeil United States 12 425 1.0× 316 1.4× 152 1.3× 28 0.3× 118 1.4× 17 685
Jyotsna Reddy United States 10 704 1.7× 278 1.2× 82 0.7× 40 0.4× 172 2.1× 11 901
Craig T. Wallington‐Beddoe Australia 14 501 1.2× 143 0.6× 76 0.7× 144 1.4× 79 1.0× 32 658
Andrea Ghelli Luserna di Rorà Italy 13 513 1.2× 303 1.3× 33 0.3× 54 0.5× 98 1.2× 38 735
Lina Happo Australia 10 410 1.0× 217 0.9× 58 0.5× 41 0.4× 62 0.7× 12 641
Janice Madafiglio Australia 13 460 1.1× 361 1.5× 79 0.7× 112 1.1× 151 1.8× 18 800
Julianty Frost United Kingdom 7 525 1.3× 159 0.7× 44 0.4× 22 0.2× 217 2.6× 8 731
Natalia Liem Singapore 14 566 1.4× 302 1.3× 23 0.2× 46 0.5× 136 1.6× 18 944
Diego Serrano Spain 15 410 1.0× 278 1.2× 39 0.3× 63 0.6× 159 1.9× 25 750
Petra Laspe Germany 14 325 0.8× 104 0.4× 55 0.5× 40 0.4× 109 1.3× 19 564

Countries citing papers authored by Benjamin J. Drapkin

Since Specialization
Citations

This map shows the geographic impact of Benjamin J. Drapkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin J. Drapkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin J. Drapkin more than expected).

Fields of papers citing papers by Benjamin J. Drapkin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin J. Drapkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin J. Drapkin. The network helps show where Benjamin J. Drapkin may publish in the future.

Co-authorship network of co-authors of Benjamin J. Drapkin

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin J. Drapkin. A scholar is included among the top collaborators of Benjamin J. Drapkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin J. Drapkin. Benjamin J. Drapkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Svoboda, Robert A., et al.. (2025). KSR1 Mediates Small Cell Lung Carcinoma Tumor Initiation and Cisplatin Resistance. Molecular Cancer Research. 23(6). 553–566. 2 indexed citations
2.
Drapkin, Benjamin J., et al.. (2025). Atypical Small Cell Lung Cancer: A New Malignancy Characterized by Chromothripsis, Carcinoid Tumors, and Wild-type RB1 and TP53. Cancer Discovery. 15(1). 8–10. 1 indexed citations
3.
Floros, Konstantinos V., et al.. (2025). Myc family proteins: Molecular drivers of tumorigenesis and resistance in neuroendocrine tumors. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1880(3). 189332–189332.
4.
Kim, Chiho, Xudong Wang, Zhengshuai Liu, et al.. (2024). Induced degradation of lineage-specific oncoproteins drives the therapeutic vulnerability of small cell lung cancer to PARP inhibitors. Science Advances. 10(3). eadh2579–eadh2579. 6 indexed citations
5.
Siteni, Silvia, Mingrui Zhu, Kenian Chen, et al.. (2024). A telomere-targeting drug depletes cancer initiating cells and promotes anti-tumor immunity in small cell lung cancer. Nature Communications. 15(1). 672–672. 13 indexed citations
6.
Chen, Haobin, Benjamin J. Drapkin, & John D. Minna. (2024). Proteomics: A new dimension to decode small cell lung cancer. Cell. 187(1). 14–16. 1 indexed citations
7.
Zhang, Yuanyuan, Puneeth Iyengar, Kenneth D. Westover, et al.. (2024). Concerning Safety and Efficacy of Concurrent and Consolidative Durvalumab With Thoracic Radiation Therapy in PDL1-Unselected Stage III Non-Small Cell Lung Cancer: Brief Report. International Journal of Radiation Oncology*Biology*Physics. 121(1). 68–74. 1 indexed citations
8.
Nuñez, C, Tram Anh T. Tran, Luc Girard, et al.. (2024). Jumonji histone demethylases are therapeutic targets in small cell lung cancer. Oncogene. 43(38). 2885–2899. 2 indexed citations
9.
Drapkin, Benjamin J., et al.. (2023). P2.31-03 Lambert-Eaton Myasthenic Syndrome is Underrecognized in Small Cell Lung Cancer: An Analysis of Real-World Data. Journal of Thoracic Oncology. 18(11). S407–S408. 1 indexed citations
10.
Stanzione, Marcello, Jun Zhong, Edmond Wong, et al.. (2022). Translesion DNA synthesis mediates acquired resistance to olaparib plus temozolomide in small cell lung cancer. Science Advances. 8(19). eabn1229–eabn1229. 22 indexed citations
11.
Sanidas, Ioannis, Gaylor Boulay, Robert Morris, et al.. (2022). Chromatin-bound RB targets promoters, enhancers, and CTCF-bound loci and is redistributed by cell-cycle progression. Molecular Cell. 82(18). 3333–3349.e9. 16 indexed citations
12.
Drapkin, Benjamin J. & John D. Minna. (2021). A rational targeted therapy for platinum-resistant small-cell lung cancer. Cancer Cell. 39(4). 453–456. 5 indexed citations
13.
Drapkin, Benjamin J. & Charles M. Rudin. (2020). Advances in Small-Cell Lung Cancer (SCLC) Translational Research. Cold Spring Harbor Perspectives in Medicine. 11(4). a038240–a038240. 30 indexed citations
14.
Li, Leanne, Sheng Rong Ng, Caterina I. Colón, et al.. (2019). Identification of DHODH as a therapeutic target in small cell lung cancer. Science Translational Medicine. 11(517). 103 indexed citations
15.
Tajima, Ken, Satoru Matsuda, Toshifumi Yae, et al.. (2019). SETD1A protects from senescence through regulation of the mitotic gene expression program. Nature Communications. 10(1). 2854–2854. 39 indexed citations
16.
Farago, Anna F., Kumiko Isse, Benjamin J. Drapkin, et al.. (2018). P3.12-02 Dynamics of DLL3 and ASCL1 Expression in SCLC Over Disease Course. Journal of Thoracic Oncology. 13(10). S970–S971. 3 indexed citations
17.
Marcoux, Nicolas, Zofia Piotrowska, Anna F. Farago, et al.. (2017). Clinical outcomes for EGFR-mutant adenocarcinomas (AC) that transform to small cell lung cancer (SCLC). Annals of Oncology. 28. v540–v541. 1 indexed citations
18.
Piotrowska, Zofia, Benjamin J. Drapkin, Jeffrey A. Engelman, et al.. (2016). Plasma T790M Result Alters Treatment Options in a Previously T790 Wild-Type EGFR -Mutant Lung Cancer. Journal of Thoracic Oncology. 11(8). e95–e97. 9 indexed citations
19.
Drapkin, Benjamin J., et al.. (2009). Analysis of the mitotic exit control system using locked levels of stable mitotic cyclin. Molecular Systems Biology. 5(1). 328–328. 28 indexed citations
20.
Archambault, Vincent, Emmanuel J. Chang, Benjamin J. Drapkin, et al.. (2004). Targeted Proteomic Study of the Cyclin-Cdk Module. Molecular Cell. 14(6). 699–711. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Olaf Klingbeil Breakdown of academic impact, for papers by Jyotsna Reddy Breakdown of academic impact, for papers by Craig T. Wallington‐Beddoe Breakdown of academic impact, for papers by Andrea Ghelli Luserna di Rorà Breakdown of academic impact, for papers by Lina Happo Breakdown of academic impact, for papers by Janice Madafiglio Breakdown of academic impact, for papers by Julianty Frost Breakdown of academic impact, for papers by Natalia Liem Breakdown of academic impact, for papers by Diego Serrano Breakdown of academic impact, for papers by Petra Laspe
Rankless by CCL
2026